Breast Cancer Clinical Trial

Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage

Summary

The primary purpose of this research is to analyze the cells present in the fluid obtained via ductal lavage from the nipple of a woman with a known diagnosis of breast cancer. A portion of the lavage fluid may be used in future breast cancer biomarkers. Remaining lavage fluid will be used to analyze its biochemical composition, for investigational purposes only.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years of age
biopsy-proven unilateral invasive breast cancer of any histology or ductal carcinoma in situ
patient desires or requires treatment with mastectomy
any patient who has undergone prior excisional biopsy of their primary breast tumor must have had margins positive for disease, or must have either mammographic or ultrasonographic evidence of probable residual disease in the breast.
patients receiving induction chemotherapy remain eligible for participation in the study regardless of tumor response; those with a clinical complete response remain eligible.
voluntarily signed informed consent. -

Exclusion Criteria:

male gender
lobular carcinoma in situ as the only cancerous histology
prior margin-negative excisional biopsy of primary breast tumor, with no evidence of residual disease
patient being treated with breast conservation therapy inability to understand the nature of the procedure pregnancy and/or active lactation

Study is for people with:

Breast Cancer

Estimated Enrollment:

88

Study ID:

NCT00156260

Recruitment Status:

Terminated

Sponsor:

University of Michigan Rogel Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan Cancer Center
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

88

Study ID:

NCT00156260

Recruitment Status:

Terminated

Sponsor:


University of Michigan Rogel Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider